Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12012448 High concentration anti-C5 antibody formulations

Patent 12012448 was granted and assigned to Alexion Pharmaceuticals on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Alexion Pharmaceuticals
Alexion Pharmaceuticals
0
Date Filed
December 21, 2022
0
Date of Patent
June 18, 2024
0
Patent Applicant
Alexion Pharmaceuticals
Alexion Pharmaceuticals
0
Patent Application Number
18086031
0
Patent Citations
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7704497 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8088376 Fc variants with altered binding to FcRn
0
‌
US Patent 8323962 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 8367805 Fc variants with altered binding to FcRn
0
‌
US Patent 8802820 Fc variants with altered binding to FcRn
0
‌
US Patent 9079949 Anti-C5 antibodies having improved pharmacokinetics
0
‌
US Patent 9107861 Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics
0
‌
US Patent 9206251 Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
0
‌
US Patent 9371377 Anti-C5 antibodies having improved pharmacokinetics
0
•••
Patent Inventor Names
Stephan Ortiz
0
Jillian Gentile
0
Eric Routhier
0
Leena Philominathan
0
Bruce Mason
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12012448
0
Patent Primary Examiner
‌
Yunsoo Kim
0

Find more entities like US Patent 12012448 High concentration anti-C5 antibody formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo